Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 110

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 110
---
6  |
| Condensed Consolidated Statements of Cash Flows          |     | F-7    |
| Notes to Condensed Consolidated Financial Statements     |     | F-8    
 – F-27 |

<div align='center'>- - - - - - - - - - -

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>

To the Shareholders and Board of Directors

Revium RX.

We have audited the accompanying balance sheets of Lipovation Ltd (Predecessor)
as of 23 July, 2024 and December 31, 2023 and December 31 2022 and the related statements of comprehensive loss, changes in shareholders’
deficit and cash flows for the period ended 23 July, 2024 and for each of the two years ended 31 December 2023 and the related notes (collectively
referred to as the "financial statements").In our opinion, the financial statements present fairly, in all material respects,
the financial position of the Company as of 23 July, 2024 and December 31, 2023, and 2022 and the results of its operations and its cash
flows for the period ended 23 July, 2024 and for each of the two years in the period ended December 31, 2023, in conformity with accounting
principles generally accepted in the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our